Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Following Kite Pharma's Positive Top-Line Data, Focus Turns To Commercial Outlook
Following Kite Pharma's Positive Top-Line Data, Focus Turns To Commercial Outlook
Following Kite Pharma's Positive Top-Line Data, Focus Turns To Commercial Outlook
Submitted by
admin
on October 8, 2016 - 3:46pm
Source:
Yahoo/Benzinga
News Tags:
Kite Pharma
clinical trials
KTE-C19
CAR-T
refractory lymphoma
Headline:
Following Kite Pharma's Positive Top-Line Data, Focus Turns To Commercial Outlook
Do Not Allow Advertisers to Use My Personal information
